🇺🇸 FDA
Pipeline program

Vadadustat

AKB-6548-CI-0039

Phase 3 small_molecule completed

Quick answer

Vadadustat for Anemia Associated With Chronic Kidney Disease (CKD) is a Phase 3 program (small_molecule) at Akebia Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Akebia Therapeutics
Indication
Anemia Associated With Chronic Kidney Disease (CKD)
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials